|Bid||82.47 x 800|
|Ask||83.18 x 1100|
|Day's Range||82.28 - 83.09|
|52 Week Range||64.55 - 106.86|
|Beta (3Y Monthly)||1.33|
|PE Ratio (TTM)||24.05|
|Forward Dividend & Yield||2.02 (2.28%)|
|1y Target Est||92.46|
Instagram sensation, actress & model Emily Ratajkowski on why BABE partnership with 'The Fat Jewish' was a natural fit.
In February, Anheuser Busch aired a one-minute Bud Light commercial during the National Football League's Super Bowl championship game that taunted Molson Coors for adding corn syrup, a sweetener, to its Miller Lite and Coors Light brews. Federal court judge William Conley of the Western District of Wisconsin ruled partially in favour of Molson Coors in a lawsuit against Anheuser Busch for false advertising and misuse of the Miller and Coors trademarks.
A U.S. court on Friday barred Anheuser Busch InBev NV, the world's largest beer maker and brewer of Budweiser brand beers, from using parts of its marketing that said rival Molson Coors Brewing Co's MillerCoors used corn syrup in the production of its light beers. In February, Anheuser Busch aired a one-minute Bud Light commercial during the National Football League's Super Bowl championship game that taunted Molson Coors for adding corn syrup, a sweetener, to its Miller Lite and Coors Light brews.
A Wisconsin judge has ordered Anheuser-Busch to stop suggesting in advertising that MillerCoors' light beers contain corn syrup, wading into a fight between two beer giants that are losing market share to small independent brewers. U.S. District Judge William Conley for the Western District of Wisconsin on Friday granted a preliminary injunction sought by MillerCoors that temporarily stops Anheuser-Busch from using the words "corn syrup" in ads without giving more context. MillerCoors sued its rival in March, saying St. Louis-based Anheuser-Busch has spent as much as $30 million on a "false and misleading" campaign, including $13 million in its first commercials during this year's Super Bowl.
A U.S. court on Friday barred Anheuser Busch InBev NV, the maker of Bud Light beer, from using marketing that suggested rival Molson Coors Brewing Co's MillerCoors used corn syrup, a sweetener, in the final production of its light beers. The ruling follows a controversial one-minute Bud Light commercial aired during the National Football League championship game in February, that shamed Molson Coors for its Miller Lite and Coors Light brews containing corn syrup.
New study shows the beer industry contributes $10.2B annually to the state while supporting more than 55,000 jobs
The soda and beverages industry is set to gain from the removal of aluminum tariffs since it predominantly uses imported aluminum for packaging its products.
Anheuser-Busch InBev stock was climbing, helped by a bullish note from Guggenheim that sees better days ahead for the beer maker’s U.S. business.
Citi lowered its price target on Tesla to $191 from $238 Guggenheim named Anheuser-Busch InBev a best idea Evercore ISI upgraded Legg Mason to in-line from underperform Stephens downgraded Activision Blizzard to equal-weight from overweight Bank of America upgraded Ericsson to buy from neutral J.
The company, the world’s biggest brewer, must pay 200 million euros ($224 million) for market power abuse. The ruling, however, only scratches the surface of a major issue with Europe’s single market: its inability to ensure price convergence. The AB InBev case, which the commission began investigating in 2016, is relatively straightforward. In Belgium, the company’s Jupiler beer accounts for about 40 percent of all beer sales by volume. AB InBev was able to charge a higher price there than across the border in the Netherlands, where the beer market is more competitive.
Balyasny Asset Management is a Chicago-based multi-strategy hedge fund that was launched by Dmitry Balyasny and Scott Schroeder back in 2001. After so many years of existence and prosperity, the fund now offers additional offices in New York, Singapore, London, and Hong Kong. It had around $12.7 billion in assets under management in March 2017. […]
WellBeing Brewing Company teams up with St. Louis startup Buoy to produce an electrolyte and vitamin-infused, non-alcoholic craft beer
Cannabis company Tilray (NASDAQ:TLRY) desperately needed a win with Tuesday's release of its first quarter of 2019 earnings report. Not only is Tilray stock down more than 38% since the end of March, the share price is only one-sixth of its peak value from September of last year.Source: Shutterstock It got the win. Although the net loss per share widened year-over-year, revenue almost tripled. The top line also topped analyst estimates.Perhaps the biggest driver behind Wednesday's initial gain, however, was the discussion of Tilray's growth prospects. Already partnering with beverage giant Anheuser Busch Inbev (NYSE:BUD) to create cannabis-infused drinks, Tilray stock has massive potential. Company CEO Brendan Kennedy fueled those fires, commenting during the conference call about being "inundated" with partnership requests from Fortune 500 companies.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Retirement Stocks That Won't Wilt in a Bear Market Still, significant challenges remain, spurring a sharp reversal of Wednesday's initial rally in the TLRY stock price. TLRY Earnings RecapTilray wasn't the only name to report last quarter's earnings on Tuesday. Aurora Cannabis (NYSE:ACB) did as well.Tilray was decidedly the better performer of the two, however. As evidence, Tilray stock gained nearly 5% on Tuesday and was up another couple of percentage points early on Wednesday. ACB stock rallied about as well as TLRY stock did on Tuesday but unwound those gains and more on Wednesday.The market celebrated Tilray's sales. The company's top line of $23.0 million, even adjusted downward to $21.5 million to account for excise taxes, still topped the consensus outlook of $20.16 million. The adjusted loss of 27 cents per share of TLRY stock, while much worse than the 7-cent loss per share in the year-ago quarter, essentially met analysts' consensus target.Gross margins improved sequentially, from 20% to 23%. However, they were well off the 50% level seen during Q1 2018, before Canada had legalized recreational marijuana.The volatile margins figure reflects investments made in cultivation facilities and accounting rules about inventory valuations. To meet demand, Tilray is buying marijuana from third-party suppliers. This costs the company more than it would to grow that supply itself. That third-party supply, though, may not be a high-quality leaf.Expenses related to the acquisitions of Manitoba Harvest also took a toll on profitability.When all was said and done though, investors couldn't get over the subtle but telling shift in selling prices. While sales volume more than doubled to 3,012 kilograms, the average selling price fell from $5.94 per gram a year ago to $5.60 per gram last quarter. That slide at least partially reflects the ongoing commoditization of marijuana. Unfortunately, this trend will continue to drive prices lower until only the cost-conscious, high-scale players are left. Perspective Required for TLRY StockTake last quarter's numbers for Tilray stock with a grain of salt, for better or worse. It, like all other marijuana stocks, represents a moving target for several reasons.One of them is the simple fact that the cannabis market in Canada is new. Prior to October, there was no legal adult-use revenue to report.The purchase of Manitoba Harvest also added food sales of $5.6 million to the mix, but only for part of the quarter. It's also arguable that Tilray may be able to better distribute Manitoba's goods better than Manitoba could on its own. If so, it could set the stage for tremendous growth going forward.One area where Tilray is lacking is its international exposure. Overseas sales only totaled $1.8 million last quarter. The right tweaks, however, could readily change that for the better.Still, Tilray boasts some of the primo deals with major names. Aside from the Anheuser Busch partnership, Tilray has inked a supply deal with pharmaceutical giant Novartis (NYSE:NVS). Both could be game-changers once their upsides are fully realized. But it could take several quarters for either large company to decide what they want with their cannabis journey.Selling more marijuana at ever-shrinking prices isn't necessarily a big step in the right direction.Whatever the case, Tilray's most immediate problem is clear. "Our growth internationally and in Canada continue to be limited by lack of supply that we expect to improve over time," explained Tilray Chief Financial Officer Mark Castaneda during the earnings conference call. The company believes it could take up to two more years before supply and demand find an equilibrium. It remains to be seen where the TRLY stock price will stabilize once that equilibrium is met. Looking Ahead for Tilray StockTLRY shares may have initially shot higher in response to first-quarter earnings, but the bounce appears almost pre-planned. It was poised to take shape no matter what due to the sheer severity of the selloff leading into Tuesday's news. Little revealed about the quarter implies much has actually changed since the end of Q4. Everything has just scaled up, including the loss, and the bears were relentless.Those same bears dug in again on Wednesday, recognizing that simply selling marijuana doesn't ensure meaningful or even modest profitability.That's also true of rival marijuana companies, by the way. The entire industry is spending huge sums of money to garner a piece of a market that may not justify the expenditures.Though he was speaking of the decision to establish more capacity rather than arrange for more cultivation, Kennedy's comment about believing "all the hype 18 months ago" rang out alarmingly. He essentially summarized the hype surrounding the cannabis market for the past year-and-a-half.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 10 Retirement Stocks That Won't Wilt in a Bear Market * 5 Consumer Stocks Ready to Push Higher * 3 of the Best ETFs to Buy for a Play on Gold Stocks Compare Brokers The post Tilray Stock Is Red-Hot, But It's Fundamentally Flawed appeared first on InvestorPlace.
BNP Paribas SA, Citigroup Inc., HSBC Holdings Plc have been brought on as joint bookrunners for the planned Hong Kong IPO, according to the people, who asked not to be identified because the information is private. AB InBev is targeting a July listing for the business in a deal that could raise at least $5 billion, Bloomberg News reported last week.
Anheuser-Busch has wrapped up work on a large solar energy project that will help power a brewery in central New York state. The 2.76-megawatt solar farm will produce enough energy to brew more than 3 million cases of beer. St. Louis-based Anheuser-Busch, part of Belgium-based AB Inbev, will be the sole recipient of the power generated at the facility, which is 6 miles (10 kilometers) from the company's brewery in Baldwinsville, near Syracuse.New York state kicked in $1.1 million in incentives to support the project.
AB InBev (BUD) is a favored stock due to strong sales trends, strength in global brands and robust outlook. However, soft earnings trend due to currency headwinds and cost inflation cannot be ignored.
In buying Dogfish Head, Boston Beer is betting acquisitions will continue to drive growth in a core business that's stagnating.
By acquiring Delaware craft brewer Dogfish Head for $300 million, Boston Beer won more than just growth. Perhaps, it's found a successor.
For Volkswagen AG, Thyssenkrupp AG and Anheuser-Busch InBev NV, those are no obstacles to planning massive IPOs. All three companies have announced stock offerings in the past week for businesses with valuations in the tens of billions of dollars. Executives are betting that the market turmoil will have calmed down, and investors will have forgotten Uber Technologies Inc.’s disastrous IPO, by the time they’re ready to price those sales.
Budweiser Brewing Company APAC Ltd. filed on Friday to sell shares in Hong Kong, in what may be the city’s biggest initial public offering of the year. AB InBev is targeting a July listing for the unit that could raise at least $5 billion, Crystal Tse and Daniela Wei of Bloomberg News reported, citing people familiar with the matter. Partakers will get a share of a business that has a lock on the most lucrative segment of the world’s biggest beer market, China, as well as ranking first in its next two biggest markets: Australia and South Korea.
Guggenheim analyst Laurent Grandet explains why Anheuser Busch Inbev is one of his firm's top investment ideas.